⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9189153 | 0.72 | — | — | |
| SCHEMBL9182682 | 0.67 | — | — | |
| SCHEMBL9408235 | 0.67 | — | — | |
| SCHEMBL9217068 | 0.65 | — | — | |
| SCHEMBL9185733 | 0.64 | — | — | |
| SCHEMBL602012 | 0.61 | — | — | |
| SCHEMBL575696 | 0.61 | — | — | |
| SCHEMBL513911 | 0.61 | — | — | |
| SCHEMBL5088019 | 0.61 | — | — | |
| SCHEMBL82086 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107759791-B | Organosilicon polymer containing silicon-oxygen eight-membered ring, crosslinked body and preparation method | 北京航空航天大学 | 2021-07-06 | — | — | CN | disclosed |
| EP-1890357-B1 | NONAQUEOUS ELECTROLYTE SOLUTION, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CARBONATE COMPOUND | MITSUBISHI CHEM CORP (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-2339684-A2 | Nonaqueous electrolytic solution, nonaqueous electrolyte secondary cell, and carbonate compounds | Mitsubishi Chemical Corporation (JP) | 2011-06-29 | — | — | EP | disclosed |
| EP-1890357-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CARBONATE COMPOUND | Mitsubishi Chemical Corporation (JP) | 2008-02-20 | — | — | EP | disclosed |
| US-6506775-B1 | Treatment of a gastrointestinal disorder; a central nervous system (CNS) adverse conditions caused by Heliobacter pylori; or angiogenesis especially CNS disorders in a mammalian subject, especially humans. | PFIZER INC | 2003-01-14 | — | — | US | disclosed |
| US-6329396-B1 | TREATMENT OF GASTROINTESTINAL DISORDERS CENTRAL NERVOUS SYSTEM (CNS) DISORDERS; INFLAMMATORY DISEASE; EMESIS; URINARY INCONTINENCE; PAIN; MIGRAINE; SUNBURN; DISEASES, DISORDERS AND ADVERSE CONDITIONS CAUSED BY HELIOBACTER PYLORI; OR | PFIZER INC. | 2001-12-11 | — | — | US | disclosed |
| EP-0396364-B1 | Copolymers of vinyl carbonate and vinyl carbamate as contact lens material | BAUSCH & LOMB (US) | 1997-06-11 | — | — | EP | disclosed |
| EP-0588227-B1 | Cathodic electrodeposition baths with fluoro containing additives, method for preparation and their use for multi-layer coatings | HERBERTS & CO GMBH (DE) | 1995-09-13 | — | — | EP | disclosed |
| EP-0588227-A1 | Cathodic electrodeposition baths with fluoro containing additives, method for preparation and their use for multi-layer coatings | Herberts Gesellschaft mit beschränkter Haftung (DE) | 1994-03-23 | — | — | EP | disclosed |
| EP-0396364-A2 | Novel vinyl carbonate and vinyl carbamate contact lens material monomers | BAUSCH & LOMB INCORPORATED (US) | 1990-11-07 | — | — | EP | disclosed |